Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02746484
Recruitment Status : Completed
First Posted : April 21, 2016
Last Update Posted : January 18, 2017
Sponsor:
Collaborator:
University of Milano Bicocca
Information provided by (Responsible Party):
Fondazione Don Carlo Gnocchi Onlus

Brief Summary:

The Ability research project, funded in Italy within the Smart Cities and Smart Communities funding program (MInistry of University and Research, Operational Regional Programme, Lombardy, Axis 1, Operational Regional Programme - European Funding for Regional Development 2007-2013), aims at developing and testing the efficacy and the impact of a Personal Smart Health Community able to provide innovative trajectories for people with cognitive impairment, putting them at the core of a continuous and intertwining treatment and support from both formal (e.g. physicians) and informal (e.g. near relatives) caregivers, with special focus on home-based care.

Within this framework of the Ability project the investigators test the efficacy of the home-based motor-cognitive rehabilitation program delivered with two different approaches: the Ability platform versus the usual care program


Condition or disease Intervention/treatment Phase
Cognitive Impairments Dementia Alzheimer Disease Other: Ability platform program Other: Usual care program Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: ABILITY - TelerehABILITation. TechnologY-enhanced Multi-domain at Home Continuum of Care Program for People With Cognitive Impairment.
Study Start Date : April 2015
Actual Primary Completion Date : October 2016
Actual Study Completion Date : October 2016

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Ability platform program
Multi-domain at home rehabilitation program delivered through the Ability platform.
Other: Ability platform program
The Ability program is an at home participant-tailored and technology-enhanced platform a) delivering tablet-based intensive (five days/a week for six weeks) motor and cognitive activities; b) monitoring from remote vital and physical health parameters (i.e., weight, Heart Rate, O2 saturation, daily steps, sleep activity).

Active Comparator: Usual care program
Usual care at home program (paper and pencil cognitive activities; promotion of physical activity according to healthcare professional's advice)
Other: Usual care program
Usual care at home program (paper and pencil cognitive activities; promotion of physical activity according to healthcare professional's advice)




Primary Outcome Measures :
  1. activities of daily living [ Time Frame: change from baseline after 8 weeks (aMCI/AD subjects) ]
    Activities of Daily Living Inventory (ADCS/ADL)

  2. behavioral symptoms [ Time Frame: change from baseline after 8 weeks (aMCI/AD subjects) ]
    Neuropsychiatric Inventory (NPI) score

  3. cognitive domain (long-term memory) [ Time Frame: change from baseline after 8 weeks (aMCI/AD subjects) ]
    Free and Cued Selective Recall Test (FCSRT) score

  4. cognitive domain (language) [ Time Frame: change from baseline after 8 weeks (aMCI/AD subjects) ]
    Fluency score

  5. cognitive domain (frontal-executive functions) [ Time Frame: change from baseline after 8 weeks (aMCI/AD subjects) ]
    Trail Making Test (TMT) score

  6. quality of life [ Time Frame: change from baseline after 8 weeks (aMCI/AD subjects) ]
    Dementia Quality of Life (D-QoL) Instrument

  7. coping strategies [ Time Frame: change from baseline after 8 weeks (aMCI/AD subjects) ]
    Coping Orientation for Problems Experienced - Brief Version (Brief COPE)

  8. global cognitive level [ Time Frame: change from baseline after 12 months (aMCI/AD subjects) ]
    Montreal Cognitive Asssessment (MoCA) score


Secondary Outcome Measures :
  1. activities of daily living [ Time Frame: change from baseline after 12 months (aMCI/AD subjects) ]
    Activities of Daily Living Inventory (ADCS/ADL)

  2. conversion rate MCI versus AD [ Time Frame: change from baseline after 12 months (aMCI subjects) ]
    conversion rate score

  3. cognitive domain - long term memory [ Time Frame: change from baseline after 12 months (aMCI/AD subjects) ]
    Free and Cued Selective Recall Test (FCSRT) score

  4. cognitive domain - language [ Time Frame: change from baseline after 12 months (aMCI/AD subjects) ]
    Fluency score

  5. cognitive domain - frontal executive functions [ Time Frame: change from baseline after 12 months ]
    Trail Making Test (TMT) score

  6. quality of life [ Time Frame: change from baseline after 12 months ]
    Dementia Quality of Life (D-QoL) Instrument

  7. coping strategies [ Time Frame: change from baseline after 12 months ]
    Coping Orientation for Problems Experienced - Brief Version (Brief COPE)

  8. caregiver quality of life [ Time Frame: change from baseline after 8 weeks and after 12 months ]
    Psychological Well-Being (PWB) scale

  9. caregiver coping strategies [ Time Frame: change from baseline after 8 weeks and after 12 months ]
    Coping Orientation for Problems Experienced - Brief Version (Brief COPE)

  10. caregiver burden [ Time Frame: change from baseline after 8 weeks and after 12 months ]
    Caregiver Burden Inventory (CBI)

  11. caregiver affect [ Time Frame: change from baseline after 8 weeks and after 12 months ]
    Positive and Negative Affect Schedule (PANAS)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   65 Years to 85 Years   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • diagnosed as mild AD or MCI due to AD (Albert et al, 2011) according to DSM 5 diagnostic criteria (American Psychiatric Association, 2013);
  • MMSE score >18
  • school attendance (≥ 3 years).

Exclusion Criteria:

  • dysmetria;
  • serious deficits in visual acuity, acoustic perception, and in routine communication skills.
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Fondazione Don Carlo Gnocchi Onlus
ClinicalTrials.gov Identifier: NCT02746484    
Other Study ID Numbers: FdG_AD_02
First Posted: April 21, 2016    Key Record Dates
Last Update Posted: January 18, 2017
Last Verified: January 2017
Additional relevant MeSH terms:
Layout table for MeSH terms
Alzheimer Disease
Cognitive Dysfunction
Dementia
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Tauopathies
Neurodegenerative Diseases
Neurocognitive Disorders
Mental Disorders
Cognition Disorders